Analyst Price Targets — CALC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 20, 2024 6:51 am | Leland Gershall | Oppenheimer | $14.00 | $5.45 | StreetInsider | Oppenheimer Reiterates Outperform Rating on CalciMedica (CALC) |
| November 22, 2022 2:31 pm | Christopher Raymond | Raymond James | $392.00 | $146.90 | TheFly | Piper Sandler keeps Neutral on Graybug Vision following CalciMedica merger news |
| May 18, 2022 9:13 pm | Christopher Raymond | Piper Sandler | $392.00 | $171.81 | TheFly | Graybug Vision price target lowered to $2 from $4 at Piper Sandler |
Latest News for CALC
Internal and external reviews of all available safety data from the Phase 2 KOURAGE trial in acute kidney injury (AKI) did not identify evidence of a drug-related toxicity with Auxora™ D esign of pivotal program in acute pancreatitis (AP) expected in 1H 2026 JCI Insight publication of preclinical data demonstrates CM5480 as a potential differentiated therapy in pulmonary arterial hypertension (PAH); IND submission…
CalciMedica, Inc. (NASDAQ: CALC) shares are down on Wednesday after the company announced the discontinuation of its Phase 2 KOURAGE clinical trial.
Safety concern warrants reevaluation of study design, including enrollment criteria Potential future trial with Auxora™ in AKI to be evaluated after data analysis LA JOLLA, Calif., Jan. 28, 2026 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute…
EADSY lands a firm order for 30 A320neo aircraft from CALC, reinforcing strong global demand for its fuel-efficient single-aisle aircraft.
CalciMedica Inc. (NASDAQ: CALC - Get Free Report) traded down 2.1% during trading on Tuesday. The company traded as low as $5.55 and last traded at $5.73. 44,801 shares were traded during mid-day trading, a decline of 51% from the average session volume of 92,307 shares. The stock had previously closed at $5.85. Wall Street
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CALC.
U.S. House Trading
No House trades found for CALC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.